MIND diet for adults with multiple sclerosis
Official title: Randomized Controlled Trial of MIND Diet for Neuroprotection and Symptom Management in MS
Run by Icahn School of Medicine at Mount Sinai · NCT06992115 · Data updated 2026-11-12
This program will test whether following the MIND diet for one year helps brain health and reduces MS symptoms in adults with multiple sclerosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | July 16, 2025 |
| Main results expected | April 30, 2029 |
| Study ends | April 30, 2029 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT06992115 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with a diagnosis of multiple sclerosis, a baseline MIND diet score of 8 or less, and who are not pregnant are ideal candidates.
✕Probably not a fit
People with additional neurodegenerative or serious medical conditions, those planning pregnancy, or individuals already following a MIND-like diet (score above 8) may be unlikely to gain benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, stratified early phase II trial assigns adults with MS to either a one-year MIND dietary intervention with dietitian-led education and virtual support groups, or to a control arm that continues their usual diet and receives MS-related education unrelated to diet. Participants complete baseline, 6-month, and 12-month in-person visits with functional and cognitive testing, provide blood and stool samples, and complete online questionnaires. The intervention arm receives intensive virtual small-group meetings weekly for the first month and then monthly through month 12 to support MIND diet adherence. Randomization is stratified by MS phenotype and treatment type to balance groups.
Why it matters
Potential benefit: If successful, the MIND diet could offer a low-risk way to support brain health and reduce symptoms for people with MS.
How similar studies have gone: MIND and Mediterranean-style diets have shown cognitive and neuroprotective signals in aging and dementia research, but randomized evidence in MS is limited, making this a relatively novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ages 18-70 years, inclusive * MS diagnosis, on any treatment (including no treatment) * MIND diet score of ≤9 at baseline Exclusion Criteria: * Diagnosis of an additional neurodegenerative disease (e.g. Alzheimer's) or other serious neurological condition (e.g. stroke) * Current serious medical condition that could impact the ability to participate or influence study results (e.g. cancer, HIV) * Pregnancy/planning during study period
Where it's running
-
Mount Sinai Hospital
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Ilana B Katz Sand, MD — Icahn School of Medicine at Mount Sinai
- Study coordinator: Claire E Wigley, Bsc, BSPH
- Email: claire.wigley@mssm.edu
- Phone: (212) 241-3759
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.